142 related articles for article (PubMed ID: 17311022)
1. Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression.
Dubois L; Dresselaers T; Landuyt W; Paesmans K; Mengesha A; Wouters BG; Van Hecke P; Theys J; Lambin P
Br J Cancer; 2007 Mar; 96(5):758-61. PubMed ID: 17311022
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours.
Dresselaers T; Theys J; Nuyts S; Wouters B; de Bruijn E; Anné J; Lambin P; Van Hecke P; Landuyt W
Br J Cancer; 2003 Nov; 89(9):1796-801. PubMed ID: 14583786
[TBL] [Abstract][Full Text] [Related]
3. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
[TBL] [Abstract][Full Text] [Related]
4. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients.
Nemunaitis J; Cunningham C; Senzer N; Kuhn J; Cramm J; Litz C; Cavagnolo R; Cahill A; Clairmont C; Sznol M
Cancer Gene Ther; 2003 Oct; 10(10):737-44. PubMed ID: 14502226
[TBL] [Abstract][Full Text] [Related]
5. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.
King I; Bermudes D; Lin S; Belcourt M; Pike J; Troy K; Le T; Ittensohn M; Mao J; Lang W; Runyan JD; Luo X; Li Z; Zheng LM
Hum Gene Ther; 2002 Jul; 13(10):1225-33. PubMed ID: 12133275
[TBL] [Abstract][Full Text] [Related]
7. Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression.
Perez OD; Logg CR; Hiraoka K; Diago O; Burnett R; Inagaki A; Jolson D; Amundson K; Buckley T; Lohse D; Lin A; Burrascano C; Ibanez C; Kasahara N; Gruber HE; Jolly DJ
Mol Ther; 2012 Sep; 20(9):1689-98. PubMed ID: 22547150
[TBL] [Abstract][Full Text] [Related]
8. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
9. Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/prodrug therapy.
Hidaka A; Hamaji Y; Sasaki T; Taniguchi S; Fujimori M
Biosci Biotechnol Biochem; 2007 Dec; 71(12):2921-6. PubMed ID: 18159091
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
11. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
12. Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy.
Sun CH; Berg K; Hirschberg H
Methods Mol Biol; 2019; 1895():165-176. PubMed ID: 30539537
[TBL] [Abstract][Full Text] [Related]
13. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
14. Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.
Conrad C; Miller CR; Ji Y; Gomez-Manzano C; Bharara S; McMurray JS; Lang FF; Wong F; Sawaya R; Yung WK; Fueyo J
Cancer Gene Ther; 2005 Mar; 12(3):284-94. PubMed ID: 15650766
[TBL] [Abstract][Full Text] [Related]
15. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.
Pederson LC; Vickers SM; Buchsbaum DJ; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
J Gastrointest Surg; 1998; 2(3):283-91. PubMed ID: 9841986
[TBL] [Abstract][Full Text] [Related]
16. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
[TBL] [Abstract][Full Text] [Related]
17. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
[TBL] [Abstract][Full Text] [Related]
18. Bacterial cytosine deaminase mutants created by molecular engineering show improved 5-fluorocytosine-mediated cell killing in vitro and in vivo.
Fuchita M; Ardiani A; Zhao L; Serve K; Stoddard BL; Black ME
Cancer Res; 2009 Jun; 69(11):4791-9. PubMed ID: 19487291
[TBL] [Abstract][Full Text] [Related]
19. Image-guided enzyme/prodrug cancer therapy.
Li C; Penet MF; Winnard P; Artemov D; Bhujwalla ZM
Clin Cancer Res; 2008 Jan; 14(2):515-22. PubMed ID: 18223227
[TBL] [Abstract][Full Text] [Related]
20. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors.
Nakamura T; Sasaki T; Fujimori M; Yazawa K; Kano Y; Amano J; Taniguchi S
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2362-6. PubMed ID: 12506973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
